A Gene Variant in IRF3 Impacts On the Clinical Outcome of Acute Myeloid Leukemia (AML) Patients Submitted to Allogeneic Stem Cell Transplantation (allo-SCT)

被引：0
|
作者：
Martin-Antonio, Beatriz
Suarez-LLedo, Maria
Arroyes, Montserrat
Fernandez-Aviles, Francesc [1 ]
Martinez, Carmen
Rovira, Montserrat
Espigado, Ildefonso [2 ]
Gallardo, David [3 ]
Bosch, Anna [4 ]
Buno, Ismael [5 ]
Martinez-Laperche, Carolina [6 ]
Jimenez-Velasco, Antonio [7 ]
De La Camara, Rafael [8 ]
Brunet, Salut [9 ]
Nieto, Jose B. [10 ]
Urbano-Ispizua, Alvaro [11 ]
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] Hosp Univ Virgen del Rocio, Seville, Spain
[3] ICO Hosp Josep Trueta, Girona, Spain
[4] Hosp Josep Trueta, Girona, Spain
[5] Gregorio Maranon Hlth Res Inst IISGM, Madrid, Spain
[6] Gregorio Maranon Gen Univ Hosp, Dept Hematol, Madrid, Spain
[7] Hosp Carlos Haya, Malaga, Spain
[8] Hosp Univ De La Princesa, Madrid, Spain
[9] Hosp Santa Creu & Sant Pau, Barcelona, Spain
[10] Hosp Morales Meseguer, Murcia, Spain
[11] IDIBAPS, Hosp Clin, Inst Hematol & Oncol, Barcelona, Spain
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.468.468
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
468
引用
下载
收藏
页数：2
相关论文
共 50 条
  • [41] Allogeneic stem cell transplantation (allo-SCT) with sequential conditioning in patients with relapsed/refractory acute lymphoblastic leukemia: A report from EBMT acute leukemia working party
    Bazarbachi, Abdul Hamid
    Al Hamed, Rama
    Myriam, Labopin
    Afanasyev, Boris
    Hamladji, Rose-Marie
    Dietrich, Beelen
    Arnold, Ganser
    Christof, Scheid
    Wu Depei
    Donald, Bunjes
    Stepensky, Polina
    Tischer, Johanna
    Kroeger, Nicolaus
    Peric, Zina
    Giebel, Sebastian
    Nagler, Arnon
    Mohty, Mohamad
    BONE MARROW TRANSPLANTATION, 2019, 54 : 152 - 152
  • [42] Graft-Versus-Leukemia (GVL) Effect After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) as Treatment for Acute Myeloid Leukemia (AML): a Survey From the Acute Leukemia Working Party of the EBMT
    Baron, Frederic
    Labopin, Myriam
    Mohty, Mohamad
    Basara, Nadezda
    Niederwieser, Dietger
    Milpied, Noel-Jean
    Cornelissen, J. J.
    Malm, Claes
    Sengeloev, Henrik
    Blaise, Didier
    Janssen, Jeroen J. W. M.
    Petersen, Eefke
    Socie, Gerard
    Rocha, Vanderson
    BLOOD, 2009, 114 (22) : 1284 - 1285
  • [43] What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?
    Steffen T. Simon
    Anne Pralong
    Michael Hallek
    Christoph Scheid
    Udo Holtick
    Marco Herling
    Annals of Hematology, 2021, 100 : 1377 - 1389
  • [44] What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?
    Simon, Steffen T.
    Pralong, Anne
    Hallek, Michael
    Scheid, Christoph
    Holtick, Udo
    Herling, Marco
    ANNALS OF HEMATOLOGY, 2021, 100 (06) : 1377 - 1389
  • [45] Comparison of Matched-Sibling Donors Versus Unrelated Donors in Allogeneic Stem Cell Transplantation (allo-SCT) for Primary Refractory Acute Myeloid Leukemia (PRF AML): A Report of 1041 Patients from the Acute Leukemia Working Party of the EBMT
    Brissot, Eolia
    Labopin, Myriam
    Stelljes, Matthias
    Ehninger, Gerhard
    Stuhler, Gernot
    Finke, Jurgen
    Kolb, Hans Jochem
    Ganser, Arnold
    Schaefer-Eckart, Kerstin
    Kroeger, Nicolaus
    Bunjes, Donald
    Mielke, Stephan
    Bethge, Wolfgang
    Tabrizi, Reza
    Peter, Kalhs
    Blau, Igor W.
    Glass, Bertran
    Vitek, Antonin
    Gramatzki, Martin
    Holler, Ernst
    Schmid, Christoph
    Esteve, Jordi
    Nagler, Arnon
    Mohty, Mohamad
    BLOOD, 2015, 126 (23)
  • [46] Chemotherapy followed by donor lymphocyte infusions (DLI) for treatment of acute leukemia recurrence after allogeneic stem cell transplantation (allo-SCT).
    Taylor, K
    Finiewicz, KJ
    Moreb, JS
    Reddy, V
    Khan, SA
    Boyette, R
    Shroff, S
    Roque, D
    Manion, K
    Wingard, JR
    BLOOD, 2000, 96 (11) : 350B - 350B
  • [47] Factors determining the Kinetics of Disease Relapse after Allogeneic Stem Cell Transplantation (allo-SCT) for Acute Myeloid Leukaemia (AML): a survey from the Acute Leukaemia Working Party of the EBMT
    Craddock, C.
    Labopin, M.
    Socie, G.
    Huyn, A.
    Deconinck, E.
    Volin, L.
    Milpied, N.
    Bourhis, J. -H.
    Rambaldi, A.
    Chevallier, P.
    Cornelissen, J.
    Blaise, D.
    Maertens, J.
    Schmid, C.
    Nagler, A.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S82 - S83
  • [48] MIRNA BIOMARKER OF CLINICAL OUTCOME IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION
    Koldehoff, M.
    Maniera, C.
    Elmaagacli, A. H.
    Beelen, D. W.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S484 - S484
  • [49] The outcome of children with acute myeloid leukemia (AML) post-allogeneic stem cell transplantation (SCT) is not improved by the addition of etoposide to the conditioning regimen
    Ayas, Mouhab
    Al-Seraihi, Amal
    Al-Mahr, Mohamad
    Al-Jefri, Abdullah
    Belgaumi, Assim
    Elhassan, Ibrahim
    El-Solh, Hassan
    PEDIATRIC BLOOD & CANCER, 2006, 47 (07) : 926 - 930
  • [50] A constitutional variant in the transcription factor EP300 strongly influences the clinical outcome of patients submitted to allo-SCT
    Martin-Antonio, B.
    Alvarez-Laderas, I.
    Cardesa, R.
    Marquez-Malaver, F.
    Baez, A.
    Carmona, M.
    Falantes, J.
    Suarez-Lledo, M.
    Fernandez-Aviles, F.
    Martinez, C.
    Rovira, M.
    Espigado, I.
    Urbano-Ispizua, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 (09) : 1206 - 1211
12345